122 related articles for article (PubMed ID: 2474294)
1. Production and characterization of antibodies to advanced glycation products on proteins.
Nakayama H; Taneda S; Kuwajima S; Aoki S; Kuroda Y; Misawa K; Nakagawa S
Biochem Biophys Res Commun; 1989 Jul; 162(2):740-5. PubMed ID: 2474294
[TBL] [Abstract][Full Text] [Related]
2. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure.
Horiuchi S; Araki N; Morino Y
J Biol Chem; 1991 Apr; 266(12):7329-32. PubMed ID: 2019568
[TBL] [Abstract][Full Text] [Related]
5. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.
Neelofar K; Arif Z; Ahmad J; Alam K
PLoS One; 2017; 12(2):e0172074. PubMed ID: 28192530
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antibodies to advanced glycosylation end products on protein.
Nakayama H; Taneda S; Mitsuhashi T; Kuwajima S; Aoki S; Kuroda Y; Misawa K; Yanagisawa K; Nakagawa S
J Immunol Methods; 1991 Jun; 140(1):119-25. PubMed ID: 1905740
[TBL] [Abstract][Full Text] [Related]
7. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end-products prepared in solution under high pressure contain epitopes distinct from those formed in the dry reaction at high temperature.
Staniszewska M; Jarosz J; Jon M; Gamian A
Arch Immunol Ther Exp (Warsz); 2005; 53(1):71-8. PubMed ID: 15761378
[TBL] [Abstract][Full Text] [Related]
9. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.
Ikeda K; Higashi T; Sano H; Jinnouchi Y; Yoshida M; Araki T; Ueda S; Horiuchi S
Biochemistry; 1996 Jun; 35(24):8075-83. PubMed ID: 8672512
[TBL] [Abstract][Full Text] [Related]
10. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
Booth AA; Khalifah RG; Todd P; Hudson BG
J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
[TBL] [Abstract][Full Text] [Related]
11. Reactivities of D-glucose and D-fructose during glycation of bovine serum albumin.
Yeboah FK; Alli I; Yaylayan VA
J Agric Food Chem; 1999 Aug; 47(8):3164-72. PubMed ID: 10552625
[TBL] [Abstract][Full Text] [Related]
12. Fructose-related glycation.
Oimomi M; Nakamichi T; Ohara T; Sakai M; Igaki N; Hata F; Baba S
Diabetes Res Clin Pract; 1989 Aug; 7(2):137-9. PubMed ID: 2776653
[TBL] [Abstract][Full Text] [Related]
13. Protein glycation: creation of catalytic sites for free radical generation.
Yim MB; Yim HS; Lee C; Kang SO; Chock PB
Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
[TBL] [Abstract][Full Text] [Related]
14. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA.
Münch G; Keis R; Wessels A; Riederer P; Bahner U; Heidland A; Niwa T; Lemke HD; Schinzel R
Eur J Clin Chem Clin Biochem; 1997 Sep; 35(9):669-77. PubMed ID: 9352229
[TBL] [Abstract][Full Text] [Related]
15. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus.
Arif B; Ashraf JM; Moinuddin ; Ahmad J; Arif Z; Alam K
Arch Biochem Biophys; 2012 Jun; 522(1):17-25. PubMed ID: 22516656
[TBL] [Abstract][Full Text] [Related]
16. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
[TBL] [Abstract][Full Text] [Related]
17. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo.
Obayashi H; Nakano K; Shigeta H; Yamaguchi M; Yoshimori K; Fukui M; Fujii M; Kitagawa Y; Nakamura N; Nakamura K; Nakazawa Y; Ienaga K; Ohta M; Nishimura M; Fukui I; Kondo M
Biochem Biophys Res Commun; 1996 Sep; 226(1):37-41. PubMed ID: 8806589
[TBL] [Abstract][Full Text] [Related]
18. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro.
Sharma SD; Pandey BN; Mishra KP; Sivakami S
J Biochem Mol Biol Biophys; 2002 Aug; 6(4):233-42. PubMed ID: 12186738
[TBL] [Abstract][Full Text] [Related]
19. Formation of the molten globule-like state during prolonged glycation of human serum albumin.
Sattarahmady N; Moosavi-Movahedi AA; Ahmad F; Hakimelahi GH; Habibi-Rezaei M; Saboury AA; Sheibani N
Biochim Biophys Acta; 2007 Jun; 1770(6):933-42. PubMed ID: 17368729
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the impact of glucosylation on human serum albumin: A multi-technique approach.
Neelofar KM; Ahmad J; Arif Z; Alam K
Int J Biol Macromol; 2016 Nov; 92():881-891. PubMed ID: 27492562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
